trending Market Intelligence /marketintelligence/en/news-insights/trending/EsC9szOzHVXZWSIOEiPftA2 content esgSubNav
In This List

VANC Pharma cancels private placement, extends closing of HealthTab deal

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


VANC Pharma cancels private placement, extends closing of HealthTab deal

VANC Pharmaceuticals Inc. said it did not proceed with a previously announced nonbrokered private placement of common shares and warrants.

The company had planned to raise C$1.3 million through the placement, which was announced Jan. 30.

Further, VANC Pharmaceuticals extended the closing of its previously announced acquisition of HealthTab Inc. to April 30.